ASHLEY TOBEN: Open Payments
NPI 1831844125 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,144 in 24 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $15 · 2025 $1,144
Food & beverage: $669Consulting: $475
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 3 | $642 |
| Grifols USA, LLC | 4 | $161 |
| GlaxoSmithKline, LLC. | 10 | $146 |
| Amgen Inc. | 2 | $66 |
| Insulet Corporation | 1 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Baxter Healthcare | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Ohtuvayre, Prolastin-C Liquid, NUCALA, KRYSTEXXA, OMNIPOD, TEZSPIRE, DUPIXENT, Hillrom - Vest System Model 105 Home Care.
Industry payments across IA — which companies pay providers there.
